Search Results | Showing 541 - 550 of 3722 results for "CHina" |
| | | ... revealed 30% of investors plan to decrease their exposure to Australian assets in the coming 18 months, while India (39%) and China (35%) are attracting our investment professional's capital. Additionally, emerging markets are set to attract the capital ... |
| | | | ... Shanghai composite gave up 1.5% and the Hang Seng index plunged by 2.0% -- in contagion fears. According to The Guardian: "China confirmed 291 cases of infected patients in an update on Tuesday. There have also been reports of cases in Thailand, South ... |
| | | | ... global trade are bottoming out, a broad-based shift toward accommodative monetary policy, intermittent favorable news on US-China trade negotiations, and diminished fears of a no-deal Brexit, leading to some retreat from the risk-off environment that ... |
| | | | "Gong xi fa cai"! China celebrates its lunar new year on January 25 this year, bidding farewell to the "pig" and welcoming the 'Year of the Rat'. Beijing has every reason to be optimistic. Derogatory as it may seem to be called "a rat", this ... |
| | | | The S&P/ASX 200 Index has broken the 7000 mark following news of Trump and China finally signing a trade deal, but analysts remain wary of the new record high. The Index gained 47 points on Thursday to finish at 7041.8, setting a new record high for ... |
| | | | ... and there are reasons why it would. The outlook for the global economy is improving backed by the de-escalation of the US-China trade tensions (the phase one deal had been signed), Brexit is no longer uncertain and major global central banks continue ... |
| | | | ... Australia chief executive Adam Smith said: "Even though 2019 was characterised by high geopolitical uncertainty around the US-China trade war and Brexit, this did not drag on the long-term performance of global markets. Many who exercised patience between ... |
| | | | ... accelerate the development and commercialization of health and medical research outcomes from South Australia. The new Adelaide China Biotech Investment Fund is backed by a group of private investors based in China. Led by An LuFan, executive director ... |
| | | | ... provide massive economic benefits that are estimated at $33 trillion per year - the equivalent to the GDP of the US and China combined," he said. "It's critical that companies and policy-makers move faster to transition to a low carbon economy and ... |
| | | | The highly anticipated US-China 'phase one' trade agreement has finally come to pass - signed, sealed and delivered on January 15. The deal involves China committing to buy at least an additional US$200 billion worth of US goods and services ... |
|